Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Game-changing weight loss jabs relied on by millions of slimmers ... The drugs, which include Mounjaro, Ozempic and Wegovy, have ushered in a new era in the battle against obesity, helping dieters ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...